✦ LIBER ✦

Circulating concentrations of interleukin-6 in cancer patients and their pathogenic role in tumor-induced hypercalcemia

✍ Scribed by B. Vanderschueren; J. C. Dumon; V. Oleffe; C. Heymans; J. Gérain; J. J. Body

Publisher: Springer-Verlag
Year: 1994
Tongue: English
Weight: 518 KB
Volume: 39
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf01519980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating levels of interleukin-6 in p

Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer

✍ Drachenberg, Darrel E.; Elgamal, Abdel-Aziz A.; Rowbotham, Ron; Peterson, Mary; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 2 views

BACKGROUND. ) is a cytokine that plays a central role in host defense due to its wide range of immune and hematopoietic activities. It is found in high levels in human ejaculate, and has recently been found to regulate prostate-specific protein expression in prostate cancer cells through nonsteroida

Tumor-derived microvesicles in sera of p

Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression

✍ Christoph Bergmann; Laura Strauss; Eva Wieckowski; Malgorzata Czystowska; Andrea 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 610 KB

## Abstract ## Background Tumor‐derived membranous vesicles (MV) isolated from sera of the patients with squamous cell carcinomas of the head and neck (HNSCC) induce apoptosis of activated CD8^+^ T cells. We tested if MV molecular profile and activity correlate with disease progression. ## Method

Kinetics and correlation with body tempe

Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia

✍ A. Engel; W. V. Kern; G. Mürdter; P. Kern 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 775 KB

Bacillus Calmette-Guérin potentiates mon

Bacillus Calmette-Guérin potentiates monocyte responses to lipopolysaccharide-induced tumor necrosis factor and interleukin-1, but not interleukin-6 in bladder cancer patients

✍ Pio Conti; Marcella Reale; Michele Nicolai; Renato C. Barbacane; Fernanda C. Pla 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 881 KB

Serum and ascitic fluid levels of interl

Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer

✍ Mark M. Moradi; Linda F. Carson; Leo B. Twiggs; J. Brice Weinberg; A. F. Haney; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 728 KB

In vitro anti-tumor activity of eosinoph

In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5

✍ Licia Rivoltini; Mario Paolo Colombo; Giorgio Parmiani; Vincenzo Viggiano; Silvi 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 1004 KB

lnterleukin 2 (IL-2) administration is known to induce marked eosinophilia. To evaluate the potential role of eosinophils as anti-tumor effectors and t o understand the direct or indirect effects of IL-2 on eosinophils, the physical and functional characteristics of eosinophils obtained during IL-2